Skip to Content

Psoriatic arthritis, TNF inhibitors, and the risk of hematologic cancers

A Nordic register study has shown no increased risk of hematological cancers among psoriatic arthritis patients treated with TNF inhibitors compared with those who do not receive TNF inhibitors.

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top